A 40-year-old man presented to the emergency department with a 5-day history of fevers, sore throat, fatigue, subjective ...

Seven young boys given Bluebird's Skysona later developed blood cancers, findings that could shape how doctors balance the gene therapy’s risks against its benefit.

Whilst the events do not outline any new safety risks, the data gives a new understanding of the link between oncogenesis and ...

In this randomized controlled trial, twice daily crinecerfont use was associated with reduced daily glucocorticoid use in ...

Kerecis, the pioneer in the use of fish-skin, announces the publication of breakthrough study results in the New England ...

Prolia® (denosumab) is indicated to treat certain conditions that lead to high risk for fracture, including osteoporosis in ...

Prolia® (denosumab) is indicated to treat certain conditions that lead to high risk for fracture, including osteoporosis in postmenopausal womenTVB-009P, Teva's proposed biosimilar to Prolia, showed P ...